The Effects of Naltrexone in Opioid Detoxificatio
Phase 2
- Conditions
- opium addicted patients.Mental and behavioral disorders due to use of opioids
- Registration Number
- IRCT2013081914404N1
- Lead Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 63
Inclusion Criteria
Inclusion Criteria: Male patients who choose outpatient protocol for detoxification of opioids including opium, heroin, crack and tramadol ;filling the consent
Exclusion Criteria
Cancer; Known pain syndrome; Diabetes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical findings of withdrawal syndrome. Timepoint: 1, 4 and 10 days after the beginning of study. Method of measurement: clinical examination by researcher.
- Secondary Outcome Measures
Name Time Method